Tag: #M&A

On December 15, 2025, Swedish Orphan Biovitrum AB (Sobi), a global biopharma company based in Stockholm, announced that it has... Read more

Transaction Overview and Terms Mirum Pharmaceuticals Inc., a specialty pharmaceutical company focused on rare diseases, has reached an agreement to... Read more

The global healthcare enterprise Viatris has executed definitive agreements for the divestiture of its entire convertible preferred equity holding in... Read more

(Basel, December 8, 2025) – Sandoz Group AG (SIX: SDZ/OTCQX: SDZNY), the global leader in affordable medicines, announced the successful... Read more

A major pharmaceutical company has announced the successful completion of a plan to fully integrate its Biologics subsidiary, officially making... Read more

(MAINZ, Germany, December 3, 2025) – The biotech firm BioNTech (Nasdaq: BNTX) recently announced that the minimum condition for its... Read more

Eli Lilly announced its plan to acquire an experimental cancer therapy from Scorpion Therapeutics for a total consideration of up... Read more

The Swiss pharmaceutical giant Novartis has reached an agreement to acquire Anthos Therapeutics, a biopharmaceutical firm majority-owned by the life... Read more

Merck has successfully completed its previously announced $3.4 billion acquisition of SpringWorks Therapeutics, a biopharmaceutical company based in Stamford, Connecticut.... Read more